Aspen Neuroscience is a San Diego-based biotechnology company headed by Damian McDevitt, President and CEO. The first product in their clinical pipeline is an autologous neuron replacement therapy for sporadic Parkinson’s disease (ANPD001)
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.